Susquehanna International Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-192,900
| Closed | -$656K | – | 10587 |
|
|
2018
Q3 | $656K | Sell |
192,900
-111,600
| -37% | -$402K | ﹤0.01% | 6043 |
|
|
2018
Q2 | $1.15M | Sell |
304,500
-1,900
| -0.6% | -$9.25K | ﹤0.01% | 5055 |
|
|
2018
Q1 | $1.25M | Sell |
306,400
-85,500
| -22% | -$398K | ﹤0.01% | 4787 |
|
|
2017
Q4 | $1.82M | Buy |
391,900
+130,600
| +50% | +$720K | ﹤0.01% | 4073 |
|
|
2017
Q3 | $1.85M | Sell |
261,300
-251,800
| -49% | -$1.81M | ﹤0.01% | 4058 |
|
|
2017
Q2 | $3.71M | Sell |
513,100
-293,500
| -36% | -$1.83M | ﹤0.01% | 2807 |
|
|
2017
Q1 | $4.97M | Buy |
806,600
+671,500
| +497% | +$3.68M | ﹤0.01% | 2365 |
|
|
2016
Q4 | $792K | Sell |
135,100
-1,000
| -0.7% | -$5.46K | ﹤0.01% | 6012 |
|
|
2016
Q3 | $723K | Sell |
136,100
-58,300
| -30% | -$314K | ﹤0.01% | 5408 |
|
|
2016
Q2 | $1.29M | Buy |
194,400
+110,200
| +131% | +$616K | ﹤0.01% | 4346 |
|
|
2016
Q1 | $393K | Sell |
84,200
-180,900
| -68% | -$722K | ﹤0.01% | 6815 |
|
|
2015
Q4 | $1.34M | Sell |
265,100
-214,000
| -45% | -$1.02M | ﹤0.01% | 4829 |
|
|
2015
Q3 | $1.69M | Sell |
479,100
-237,700
| -33% | -$1.59M | ﹤0.01% | 4619 |
|
|
2015
Q2 | $7.15M | Buy |
716,800
+533,800
| +292% | +$5.72M | ﹤0.01% | 2420 |
|
|
2015
Q1 | $2.33M | Sell |
183,000
-130,500
| -42% | -$1.68M | ﹤0.01% | 4017 |
|
|
2014
Q4 | $4.44M | Sell |
313,500
-654,300
| -68% | -$10.1M | ﹤0.01% | 3075 |
|
|
2014
Q3 | $13.3M | Buy |
967,800
+248,700
| +35% | +$3.81M | 0.01% | 1802 |
|
|
2014
Q2 | $11.1M | Sell |
719,100
-6,500
| -0.9% | -$92.1K | ﹤0.01% | 2006 |
|
|
2014
Q1 | $12.4M | Buy |
725,600
+307,800
| +74% | +$4.64M | 0.01% | 1764 |
|
|
2013
Q4 | $5.41M | Sell |
417,800
-479,800
| -53% | -$5.73M | ﹤0.01% | 2839 |
|
|
2013
Q3 | $9.07M | Buy |
897,600
+410,500
| +84% | +$3.65M | ﹤0.01% | 2010 |
|
|
2013
Q2 | $3.64M | Buy |
+487,100
| New | +$3.81M | ﹤0.01% | 3037 |
|
Susquehanna International Group's KERX Position: Q3 2018 in Review
Susquehanna International Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 88,499 shares — an estimated $319K sold.
Susquehanna International Group first reported a position in KERX in Q2 2013 and held it in 20 quarters. The position peaked at $11.6M in Q4 2013. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.
- Susquehanna International Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
- Susquehanna International Group sold 88,499 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $319K.
- Susquehanna International Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 20 quarters.
- Susquehanna International Group's Keryx Biopharmaceuticals Inc position peaked at $11.6M in Q4 2013.
- 123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.
Based on Susquehanna International Group's 13F filing for Q3 2018, filed 14 Nov 2018.